ReviewJournal of advanced research2026
The advent of precision nutrigeroscience in cancer: from clinic towards molecular biology.
Review in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intersection of Precision Nutrition and Bladder Cancer: A Narrative State-of-the-Art Review of Potential Applications and Challenges.Journal of clinical medicine · 2026Review
- Dissecting the role of SEPHS1 in shaping an immunosuppressive microenvironment to promote tumor progression.Cancer immunology, immunotherapy : CII · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutrimental patterns have been deemed to have an impact on cancer development and the response to cancer therapy. Our growing understanding of cancer and host metabolism has highlighted that nutrient availability in the tumor ecosystem is a key factor in inhibiting tumor development. Subsequently, dietary interventions must take into account the specific characteristics of both the cancer and the host, which requires a detailed understanding of the mechanisms that determine the metabolic vulnerabilities in the tumor ecosystem. In this review, we provide an overview of various dietary regimens as interventions in both preclinical models and clinical studies. We discuss how dietary intervention can affect the homeostasis of the tumor ecosystem, including neoplastic, micro- and macro-environmental states that impact cancer progression and therapy. Our emphasis is on the prospects of precision nutrigeroscience, which involves developing individualized therapeutic approaches and predictors based on a thorough exploration of the mechanisms and critical factors. This approach has the potential to enhance the efficacy of anti-cancer treatments and prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.